Oxaliplatin plus 5FU/folinic acid (FUFOX regimen) in 1st line metastatic gastric cancer (MGC). Results of the Multicenter Phase II STOMOX Trial

Duyster, J. and Lorenzen, S. and Kullmann, F. and Hentrich, M. and Zumschlinge, R. and Vehling-Kaiser, U. and Seroneit, T. and Bredenkamp, R. and Peschel, C. and Lordick, F. (2005) Oxaliplatin plus 5FU/folinic acid (FUFOX regimen) in 1st line metastatic gastric cancer (MGC). Results of the Multicenter Phase II STOMOX Trial. In: 41st Annual Meeting of the American Society of Clinical Oncology, May 13-17, 2005, Orlando, Florida, USA.

Full text not available from this repository.
Item Type: Conference or Workshop Item (UNSPECIFIED)
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin I
Depositing User: Petra Gürster
Date Deposited: 14 Apr 2022 05:08
Last Modified: 14 Apr 2022 05:08
URI: https://pred.uni-regensburg.de/id/eprint/36062

Actions (login required)

View Item View Item